The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-11 of 11 articles
Periprocedural continuation versus interruption of oral anticoagulant drugs during transcatheter aortic valve implantation: rationale and design of the POPular PAUSE TAVI trial
van Ginkel DJ,
Bor WL,
Dubois CL,
Aarts HM,
Rooijakkers MJ,
van Bergeijk KH,
Rosseel L,
Veenstra L,
De Backer O,
Van Mieghem NM,
van der Kley F,
Wilgenhof A,
Leonora R,
Halim J,
Schotborgh CE,
Barbato E,
Van Der Heyden JA,
Frambach P,
Ferdinande B,
Mylotte D,
Fabris E,
Rensing BJ,
Timmers L,
Swaans MJ,
Brouwer J,
Nijenhuis VJ,
Peper J,
Vriesendorp PA,
de Laat B,
Ninivaggi M,
Stragier H,
Voskuil M,
IJsselmuiden AJ,
Hermanides RS,
Agostoni P,
van 't Hof AW,
Wykrzykowska JJ,
van Royen N,
Delewi R,
ten Berg JM
November 17, 2023 | 10.4244/EIJ-D-23-00206
Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: the multicentre European FAST-TAVI trial
Barbanti M,
van Mourik M,
Spence M,
Iacovelli F,
Martinelli G,
Muir D,
Saia F,
Bortone A,
Densem C,
van der Kley F,
Bramlage P,
Vis MM,
Tamburino C
June 20, 2019 | 10.4244/EIJ-D-18-01197
Left bundle branch block after sutureless, transcatheter, and stented biological aortic valve replacement for aortic stenosis
Regeer M,
Merkestein L,
de Weger A,
Kamperidis V,
van der Kley F,
van Rosendael P,
Ajmone Marsan N,
Klautz R,
Schalij M,
Bax J,
Delgado V
January 20, 2017 | 10.4244/EIJ-D-15-00256
Aortic valve stenosis: what do people know? A heart valve disease awareness survey of over 8,800 people aged 60 or over
September 18, 2016 | 10.4244/EIJY16M06_02
Impact of sirolimus-eluting stent implantation compared to bare-metal stent implantation for acute myocardial infarction on coronary plaque composition at nine months follow-up: a Virtual Histology intravascular ultrasound analysis. Results from the Leiden MISSION! intervention study
Atary J,
Bergheanu S,
van der Hoeven B,
Atsma D,
Bootsma M,
van der Kley F,
Zeppenfeld K,
Jukema J,
Schalij M
November 15, 2009 | 10.4244/EIJV5I5A92
Incidence, patient characteristics and predictors of aborted myocardial infarction in patients undergoing primary PCI: prospective study comparing pre- and in-hospital abciximab pretreatment
Hassan A,
Jukema W,
van der Laarse A,
Hasan-Ali H,
Wolterbeek R,
van der Kley F,
Spano F,
Atsma D,
Schalijv M
March 20, 2009
Latest news
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
PCR London Valves 2023
November 16, 2023
NEW ISSUE
PCR London Valves special edition. State-of-the-art on TMVI; the timing of TMVI; direct wire pacing for TMVR; predicting patient-prosthesis mismatch following TAVI and more
November 17, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023
AHEAD OF PRINT
Cardiac damage classification in each AS subtype
FREE ARTICLE - Masaaki Nakase et al
November 6, 2023
AHEAD OF PRINT
CAPTIS embolic protection during TAVR
FREE ARTICLE - Haim D. Danenberg et al
November 2, 2023